Recently identified as a uremic toxin, phenylacetic acid (PAA) inhibits the expression of inducible nitric oxide synthase (iNOS) and plasma membrane calcium ATPase, potentially contributing to the remodeling of arteries in patients with CKD [41]. Here, NOS2 is linked to chronic kidney disease.